Medpace Holdings Inc vs ZTO Express (Cayman) Inc. American Depositary Shares each representing one Class A ordinary share. — how do they compare? Medpace Holdings Inc trades at $611.57 (market cap $16.82B), while ZTO Express (Cayman) Inc. American Depositary Shares each representing one Class A ordinary share. trades at $20.12 (market cap $14.70B). The key difference: Medpace Holdings Inc and ZTO Express (Cayman) Inc. American Depositary Shares each representing one Class A ordinary share. are close in size by market cap, and ZTO Express (Cayman) Inc. American Depositary Shares each representing one Class A ordinary share. pays a 3.47% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | ZTO | |
|---|---|---|
Market Cap | $16.82B | $14.70B |
Volume | 223,093 | 1,484,646 |
Sector | Health | Industrials |
52-Week High | $630.19 | $25.88 |
52-Week Low | $393.42 | $18.50 |
Typical Hold Time | 14 Days | — |
Enterprise Value | $16.44B | $13.32B |
Dividend Yield | — | 3.47% |
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $617.47, up 2.19% with strong quarterly earnings beats and robust profitability metrics. The stock shows neutral technical signals with key resistance at $620, while fundamentals reveal impressive ROE of 162.15% and consistent revenue growth to $2.8B projected for 2026. Recent CEO stock sales and mixed institutional activity create balanced sentiment ahead of Q3 earnings announcement on October 21, 2026.
MEDP presents growth potential with analyst consensus target of $620.44 and strong historical execution, though elevated valuations (P/E 35.41) and insider selling warrant caution. The stock's upside depends on continued earnings delivery amid competitive medical services landscape.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →ZTO Express provides domestic and international express delivery services in China. Its network-partner model combines ZTO's sorting and trunk transportation with partners' pickup and last-mile delivery.
Read more on ZTO →